Stanford Breakthrough: Scientists Find Way to Regrow Joint Cartilage and Stop Arthritis

regrow cartilage arthritis treatment

What’s the Big News?

 

Scientists at Stanford Medicine have found a way to regrow worn-out cartilage in joints by targeting a single protein linked to aging.

 

Right now, if you develop severe osteoarthritis – the painful “wear-and-tear” disease that breaks down cartilage – doctors can only give you pain relievers or perform total joint replacement surgery. This new discovery could lead to a simple injection or pill that reverses cartilage loss, potentially making knee and hip replacements a thing of the past.

 

 

How It Works: Blocking the “Aging Enzyme”

 

The Culprit (15-PGDH): As we age, our bodies produce higher levels of a protein called 15-PGDH (a “gerozyme,” or aging enzyme). In older knees, levels of this enzyme double.

 

The Damage: High levels of this enzyme destroy a helpful molecule that tissues need to repair themselves. This causes cartilage cells to stop protecting the joint and start releasing inflammatory chemicals that break down collagen.

 

The Fix: The researchers injected a drug that blocks 15-PGDH. Without this enzyme in the way, the cells were able to start rebuilding healthy, shock-absorbing cartilage.

 

The Big Surprise: Tissues usually need stem cells to heal, but cartilage doesn’t have many stem cells. Instead of making new cells, this drug reprogrammed existing cartilage cells, flipping their genetics back into a youthful state so they could fix themselves.

 

Knee Support Wraps for Arthritis Joint Pain Relief

 

Knee Support Wraps for Arthritis Joint Pain Relief

 

 

Visit the UFlex Athletics Store

 

 

 

What Happened in Tests?

 

  • In Aging Mice: Older mice with thin, worn-down joint cartilage received the drug. Their cartilage regrew into thick, smooth, healthy tissue.

 

  • In Injured Mice (ACL Tears): About 50% of people who tear their ACL develop arthritis later in life. When mice with ACL-like injuries were given the drug for 4 weeks, it prevented arthritis from forming entirely, and the mice walked without pain.

 

  • In Human Tissue: Researchers tested the drug on human cartilage taken from knee-replacement surgeries. Within just one week, the human cells shifted into a younger profile and began showing signs of regeneration.

 

Voltaren Arthritis Pain Relief Gel

 

Voltaren Arthritis Pain Relief Gel

 

 

Shop online

 

 

 

 

What Happens Next?

 

Because an oral version of this same drug is already being tested in human clinical trials for muscle weakness (and has proven safe in Phase 1 trials), researchers hope to launch trials specifically for human knee cartilage regeneration soon.

Leave a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Scroll to Top